Judy FitzgeraldNov 121 min readLatest Breast Cancer Vaccine Trial ResultsAnixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meetinghttps://ir.anixa.com/press-releases/detail/1058/anixa-biosciences-and-cleveland-clinic#ANIX
Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meetinghttps://ir.anixa.com/press-releases/detail/1058/anixa-biosciences-and-cleveland-clinic#ANIX
Unveiling the Next Chapter: Anixa Bioscience's Promising Progress in the Fight Against Breast Cancer. Study Plans Announced for the Phase II of the Tuohy Vaccine at the Cleveland Clinic
Comments